-
1
المؤلفون: Gertjan Wolbink, Radboud J E M Dolhain, Hieronymus T W Smeele, Erik Kemper, Theo Rispens, Ineke Hubertina Crijns, Nafise Ghalandari
المساهمون: Rheumatology, AII - Inflammatory diseases, Landsteiner Laboratory
المصدر: Annals of the Rheumatic Diseases, 81(3), 402-405. BMJ Publishing Group
Annals of the rheumatic diseases, 81(3), 402-405. BMJ Publishing Group
Ghalandari, N, Kemper, E, Crijns, I H, Wolbink, G, Rispens, T, Smeele, H T & Dolhain, R J 2022, ' Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy ', Annals of the Rheumatic Diseases, vol. 81, no. 3, pp. 402-405 . https://doi.org/10.1136/annrheumdis-2021-221036Testمصطلحات موضوعية: Adult, musculoskeletal diseases, medicine.medical_specialty, rheumatoid, tumor necrosis factor inhibitors, medicine.medical_treatment, Immunology, Gestational Age, General Biochemistry, Genetics and Molecular Biology, Etanercept, Arthritis, Rheumatoid, Rheumatology, Pregnancy, Reference Values, Internal medicine, medicine, Adalimumab, Humans, Immunology and Allergy, Certolizumab pegol, skin and connective tissue diseases, business.industry, Reproducibility of Results, Fetal Blood, medicine.disease, Infliximab, TNF inhibitor, Pregnancy Complications, certolizumab pegol, Treatment Outcome, arthritis, Antirheumatic Agents, Cord blood, Rheumatoid arthritis, Female, business, etanercept, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce5acc7e391c68e3eab7bac1160cce08Test
https://doi.org/10.1136/annrheumdis-2021-221036Test -
2
المؤلفون: Young Ho Lee, Gwan Gyu Song
المصدر: Int. Journal of Clinical Pharmacology and Therapeutics. 59:760-767
مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, Network Meta-Analysis, Etanercept, law.invention, Arthritis, Rheumatoid, Pharmacotherapy, Randomized controlled trial, law, Internal medicine, Humans, Medicine, Pharmacology (medical), skin and connective tissue diseases, Adverse effect, Biosimilar Pharmaceuticals, Pharmacology, Response rate (survey), business.industry, medicine.disease, Rheumatology, Methotrexate, Treatment Outcome, Antirheumatic Agents, Meta-analysis, Rheumatoid arthritis, Drug Therapy, Combination, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d2abd5e15e7d6544d07ecd312588d28Test
https://doi.org/10.5414/cp204049Test -
3
المؤلفون: Elham Aflaki, Ahmad Gholami, Khosro Keshavarz, Jassem Azizpoor, Mehdi Rezaee
المصدر: BioMed Research International, Vol 2021 (2021)
BioMed Research Internationalمصطلحات موضوعية: Male, musculoskeletal diseases, medicine.medical_specialty, Article Subject, Cost-Benefit Analysis, Iran, Community perspective, General Biochemistry, Genetics and Molecular Biology, Etanercept, Arthritis, Rheumatoid, Internal medicine, medicine, Adalimumab, Humans, skin and connective tissue diseases, Biological Products, General Immunology and Microbiology, Joint destruction, business.industry, Anti-Inflammatory Agents, Non-Steroidal, General Medicine, Cost-effectiveness analysis, medicine.disease, Infliximab, Cross-Sectional Studies, Antirheumatic Agents, Rheumatoid arthritis, Economic evaluation, Medicine, Female, Tumor Necrosis Factor Inhibitors, Quality-Adjusted Life Years, business, Research Article, medicine.drug
وصف الملف: text/xhtml
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01ee88c434559694613e5e93c9d5b28fTest
https://doi.org/10.1155/2021/4450162Test -
4
المؤلفون: Ilan Green, Fadi Hassan, Mohammad E. Naffaa, Eugene Merzon, Avivit Golan-Cohen, Amir Saab, Ziv Paz
المصدر: Rheumatology International. 41:1905-1913
مصطلحات موضوعية: Male, musculoskeletal diseases, medicine.medical_specialty, Time Factors, Databases, Factual, Immunology, Population, Comorbidity, Etanercept, Arthritis, Rheumatoid, chemistry.chemical_compound, Sex Factors, Tocilizumab, Rheumatology, Internal medicine, medicine, Adalimumab, Humans, Immunology and Allergy, Longitudinal Studies, Israel, education, Aged, Retrospective Studies, Biological Products, education.field_of_study, business.industry, Hazard ratio, Middle Aged, medicine.disease, Golimumab, Infliximab, chemistry, Antirheumatic Agents, Rheumatoid arthritis, Female, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ca6185a025a3269717dfef1965dc8c8Test
https://doi.org/10.1007/s00296-021-04989-yTest -
5
المؤلفون: Gaston Solano, Bonnie Vlahos, Maria de la Vega, Ronald Pedersen, Ricardo Machado Xavier, Karina Santana, Generoso Guerra Bautista, César Pacheco-Tena, Cecilia Borlenghi, Annette Szumski
المصدر: Advances in Rheumatology, Vol 61, Iss 1, Pp 1-8 (2021)
Repositório Institucional da UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
Advances in Rheumatology, Volume: 61, Article number: 56, Published: 27 SEP 2021مصطلحات موضوعية: Adult, musculoskeletal diseases, medicine.medical_specialty, Visual analogue scale, Prognóstico, Diseases of the musculoskeletal system, Artrite reumatóide, Etanercept, Arthritis, Rheumatoid, Ensaio clínico, Rheumatology, Internal medicine, Post-hoc analysis, medicine, Humans, medicine.diagnostic_test, business.industry, Odds ratio, Middle Aged, RC581-607, medicine.disease, Latin America, Logistic Models, Methotrexate, Treatment Outcome, RC925-935, Erythrocyte sedimentation rate, Rheumatoid arthritis, Antirheumatic Agents, Drug Therapy, Combination, Immunologic diseases. Allergy, business, Body mass index, Tratamento farmacológico, medicine.drug
وصف الملف: application/pdf; text/html
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1137786d6eca2b490af6f7298c4374baTest
https://doaj.org/article/45dc6cec1bba47d3ab70b258815a4142Test -
6
المؤلفون: Jeong Seok Lee, Seogsong Jeong, Eun Young Lee, Seulggie Choi, Byeongzu Ghang, Sang Min Park, Daein Choi
المصدر: Seminars in Arthritis and Rheumatism. 51:685-691
مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, Etanercept, Abatacept, Arthritis, Rheumatoid, Cohort Studies, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Tocilizumab, Rheumatology, Internal medicine, Adalimumab, Humans, Medicine, 030212 general & internal medicine, 030203 arthritis & rheumatology, Tofacitinib, business.industry, medicine.disease, Golimumab, Infliximab, Anesthesiology and Pain Medicine, Pharmaceutical Preparations, chemistry, Antirheumatic Agents, Rheumatoid arthritis, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb3a011e114100e14640d728497a5b8cTest
https://doi.org/10.1016/j.semarthrit.2021.06.002Test -
7
المؤلفون: Gordana Susic, Nadina Rubio-Pérez, Despoina Maritsi, Laura Marinela Ailioaie, Sujata Sawhney, Ellen Nordal, Flavio Sztajnbok, Marija Jelušić, Gabriella Giancane, Roline M Krol, Sytze de Roock, Marco Cattalini, Claudia Saad-Magalhães, Joeri W van Straalen, Sheila Knupp Feitosa de Oliveira, Pavla Doležalová, Violeta Panaviene, Marite Rygg, Nicolino Ruperto, Tamás Constantin, Joost F Swart, Nico M Wulffraat
المصدر: Rheumatology
Rheumatology, Oxford : Oxford University Press, 2021, p. [1-10]
Rheumatology, Oxford : Oxford University Press, 2022, vol. 61, no. 5, p. 2104-2112مصطلحات موضوعية: musculoskeletal diseases, Male, medicine.medical_specialty, enthesitis-related arthritis, IBD, Arthritis, Juvenile, Inflammatory bowel disease, Gastroenterology, Etanercept, Rheumatology, Internal medicine, Adalimumab, medicine, Humans, Pharmacology (medical), Registries, Family history, Child, JIA, business.industry, Incidence (epidemiology), Incidence, medicine.disease, Inflammatory Bowel Diseases, Infliximab, Arthritis, Juvenile, digestive system diseases, Methotrexate, etanercept, inflammatory bowel disease, juvenile idiopathic arthritis, Relative risk, Antirheumatic Agents, business, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3942fe373f143ec6795cf9f918ffdcdTest
http://hdl.handle.net/11379/560137Test -
8
المؤلفون: Johan Askling, Burkhard Möller, Matija Tomšič, Lennart T H Jacobsson, Jakub Zavada, Thorvardur Jon Love, Daniela Di Giuseppe, Adrian Ciurea, Manuel Pombo-Suarez, Maria José Santos, Bjorn Gudbjornsson, Pedro Avila-Ribeiro, Catalin Codreanu, Brigitte Michelsen, Michael John Nissen, Carlos Sánchez-Piedra, Lykke Midtbøll Ørnbjerg, Karen Minde Fagerli, Bente Glintborg, Žiga Rotar, Bénédicte Delcoigne, Gareth T. Jones, Ruxandra Ionescu, Servet Yolbas, Ulf Lindström, Lucie Nekvindová, Heikki Relas, Mikkel Østergaard, Nuh Atas, Florenzo Iannone, Kari K. Eklund
المساهمون: HUS Inflammation Center, Department of Medicine, Reumatologian yksikkö, Repositório da Universidade de Lisboa
المصدر: Annals of the Rheumatic Diseases
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Lindström, U, Di Giuseppe, D, Delcoigne, B, Glintborg, B, Möller, B, Ciurea, A, Pombo-Suarez, M, Sanchez-Piedra, C, Eklund, K, Relas, H, Gudbjornsson, B, Love, T J, Jones, G T, Codreanu, C, Ionescu, R, Nekvindova, L, Závada, J, Atas, N, Yolbas, S, Fagerli, K M, Michelsen, B, Rotar, Tomšič, M, Iannone, F, Santos, M J, Avila-Ribeiro, P, Ørnbjerg, L M, Østergaard, M, Jacobsson, L T H, Askling, J & Nissen, M J 2021, ' Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration ', Annals of the Rheumatic Diseases, vol. 80, no. 11, 220097, pp. 1410-1418 . https://doi.org/10.1136/annrheumdis-2021-220097Testمصطلحات موضوعية: Male, Placebo-controlled study, Psoriatic, PLACEBO-CONTROLLED TRIAL, THERAPY, Etanercept, DOUBLE-BLIND, 0302 clinical medicine, Immunology and Allergy, Medicine, 030212 general & internal medicine, skin and connective tissue diseases, Remission Induction, Middle Aged, Tumour necrosis factor inhibitors, Treatment Outcome, arthritis, Antirheumatic Agents, Drug Therapy, Combination, Female, medicine.drug, musculoskeletal diseases, Adult, medicine.medical_specialty, Immunology, Psoriatic Arthritis, tumour necrosis factor inhibitors, General Biochemistry, Genetics and Molecular Biology, methotrexate, 03 medical and health sciences, Psoriatic arthritis, Rheumatology, Internal medicine, Adalimumab, Humans, 030203 arthritis & rheumatology, business.industry, Arthritis, Arthritis, Psoriatic, EFFICACY, medicine.disease, Infliximab, Discontinuation, Methotrexate, 3121 General medicine, internal medicine and other clinical medicine, Tumor Necrosis Factor Inhibitors, psoriatic, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::022e520d9e5e31bc0cc0baf6321a0476Test
http://europepmc.org/articles/PMC8522446Test -
9
المؤلفون: Kamran Naraghi, Désirée van der Heijde, Sarah Horton, Raluca B Dumitru, Paul Emery, Maya H Buch, Richard J. Wakefield, Elizabeth M A Hensor
المصدر: Annals of the Rheumatic Diseases, 79(4), 464-471. BMJ PUBLISHING GROUP
Emery, P, Horton, S, Dumitru, R B, Naraghi, K, Heijde, D V D, Wakefield, R, Hensor, E M A & Buch, M 2020, ' A pragmatic randomised controlled trial of Very early Etanercept and MTX versus MTX with Delayed Etanercept in RA – the VEDERA trial ', Annals of the rheumatic diseases, vol. 79, no. 4, pp. 464-471 . https://doi.org/10.1136/annrheumdis-2019-216539Testمصطلحات موضوعية: Adult, Male, musculoskeletal diseases, medicine.medical_specialty, Time Factors, medicine.drug_class, Immunology, early rheumatoid arthritis, Gastroenterology, General Biochemistry, Genetics and Molecular Biology, Etanercept, law.invention, Arthritis, Rheumatoid, Power doppler, remission, Rheumatology, Randomized controlled trial, immune system diseases, law, Early Medical Intervention, Internal medicine, medicine, Clinical endpoint, Humans, Immunology and Allergy, Rheumatoid factor, skin and connective tissue diseases, ultrasound, business.industry, anti-TNF, Exploratory analysis, Middle Aged, Methotrexate, Treatment Outcome, Antirheumatic Agents, Corticosteroid, Drug Therapy, Combination, Female, Tumor Necrosis Factor Inhibitors, business, etanercept, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3018c322797a215f651281cd655fd90Test
https://doi.org/10.1136/annrheumdis-2019-216539Test -
10
المؤلفون: Tara Gomes, Daniel McCormack, Jennifer Fenna, Diana Martins, Mina Tadrous, Sophie A Kitchen
المصدر: Scopus-Elsevier
مصطلحات موضوعية: Adult, Male, musculoskeletal diseases, medicine.medical_specialty, Cross-sectional study, Pharmaceutical Science, Pharmacy, Inflammatory bowel disease, Etanercept, Arthritis, Rheumatoid, Young Adult, Internal medicine, medicine, Humans, Medical prescription, Formulary, Biosimilar Pharmaceuticals, Reimbursement, Aged, Aged, 80 and over, Ontario, business.industry, Health Policy, Biosimilar, Middle Aged, Inflammatory Bowel Diseases, medicine.disease, Infliximab, Cross-Sectional Studies, Antirheumatic Agents, Pharmaceutical Services, Female, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f46e03b727c93910543f8af1fddfa2cdTest
https://doi.org/10.18553/jmcp.2021.27.4.444Test